Shinjo Takuya, Morita Tatsuya, Hirai Kei, Miyashita Mitsunori, Shimizu Megumi, Tsuneto Satoru, Shima Yasuo
Shinjo Clinic, Kobe, Japan.
Department of Palliative and Supportive Care, Palliative Care Team and Seirei Hospice, Seirei Mikatahara Hospital, Hamamatsu, Japan.
J Pain Symptom Manage. 2015 Jan;49(1):45-54. doi: 10.1016/j.jpainsymman.2014.04.015. Epub 2014 Jun 12.
Many surveys have evaluated patient-related barriers to pain management.
To explore associations between a preference for opioids and general attitudes toward drugs, the experience and information received as a bereaved family, and beliefs regarding a good death.
A cross-sectional survey, performed in 2010, of bereaved families of patients with cancer in palliative care units across Japan. Questionnaires were sent to 997 families.
A total of 66% of families responded. Of these, 224 responses were excluded because the family declined to participate in the study (n = 38), the patient was not receiving any opioid analgesics, and there were missing data (n = 164), or data were missing for the primary end points (n = 22). Thus, 432 responses were finally analyzed (43%). In total, 26%, 41%, and 31% of family members stated that they strongly want to receive, want to receive, or slightly want to receive opioids if needed in the future, respectively. Determinants associated with a preference for receiving opioid treatment were the following: a general appreciation of the drugs (P = 0.005), witnessing an improvement in the patient's quality of life as a result of pain relief (P = 0.003), information provided by medical professionals that the opioid could be discontinued if side effects developed (P = 0.042), and the belief that a good death was one that was free from pain and physical distress (P < 0.001).
More than 90% of bereaved families whose relatives were treated with opioid analgesics reported a preference to receive opioid analgesics for the treatment of cancer pain, if necessary, in the future.
许多调查评估了与患者相关的疼痛管理障碍。
探讨对阿片类药物的偏好与对药物的总体态度、作为丧亲家庭的经历和所获信息以及关于善终的信念之间的关联。
2010年对日本各地姑息治疗病房中癌症患者的丧亲家庭进行了一项横断面调查。向997个家庭发送了问卷。
共有66%的家庭做出了回应。其中,224份回复被排除,原因如下:家庭拒绝参与研究(n = 38)、患者未接受任何阿片类镇痛药、存在缺失数据(n = 164)或主要终点数据缺失(n = 22)。因此,最终分析了432份回复(43%)。总体而言,分别有26%、41%和31%的家庭成员表示,如果未来有需要,他们强烈希望、希望或有点希望接受阿片类药物。与接受阿片类药物治疗偏好相关的决定因素如下:对药物的总体认可(P = 0.005)、因疼痛缓解见证患者生活质量改善(P = 0.003)、医疗专业人员提供的信息表明如果出现副作用阿片类药物可以停用(P = 0.042)以及认为善终是没有疼痛和身体痛苦的死亡(P < 0.001)。
超过90%的亲属接受过阿片类镇痛药治疗的丧亲家庭表示,如果未来有必要,他们更倾向于接受阿片类镇痛药来治疗癌症疼痛。